BIOIBERICA's healthcare division has just launched its Hyal-Joint website redesign, Although most changes focus on technological and corporate image upgrades, there are also new contents.
The re-design looks for a maximum adaptation of the website to our users' needs
This website, a referral site in regard to mobility and sinovial liquid, offers their users all the information they need to care about their tendons and joints, plus all the news and novelties in that field.
With these changes, the website gains in usability, has a fresher and more actual look, and provides patients and persons interested in joint health with up to date information.
Among the most important novelties we will highlight the new section “ask a question to Dr. Theo”. In that section, Dr. Jason Theodosakis, a recognized expert in joint health, will answer all questions sent by users. Moreover, the platform offers detailed information on our products and how to use them, as well as a news section that will inform on news regarding research progress.
With these upgrades, Hyal-Joint renews its corporate image and keeps its website up to the latest standards in accessibility, providing users and customers with useful, high-quality content in a fresh, easy-to-navigate website.
Bioiberica
Established in 1975, Bioiberica has pioneered advancements in pharmaceuticals and dietary supplements that has led to the development of a global business in over 40 countries around the world.
Dedicated to research, the company has established itself as one of the most prestigious names in the industry for top quality active ingredients materials that are backed by science.
Bioiberica has become a recognized leader in joint health. Developing effective and innovative ingredients and offering an extensive collection of joint health molecules the company supplies some of the most effective ingredients available today.
Given the fact that 25% of the population is affected by some kind of joint problem, Bioiberica´s Joint Care ingredient portfolio and continuous development of promising molecules has contributed to improving manufactured joint products and, the quality of life for millions of affected consumers.
